Report copyright - 38 Oncology & Biotech News CliNiCAlTriAl repOrTS...Intra-arterial Bevacizumab Delivered Directly into the Brain Tumor The antiangiogenesis agent bevacizumab (Avastin) is approved for
Please pass captcha verification before submit form